Atomo NewsGet the app

Get the latest Science News and Discoveries

New investigational drug combining eloralintide and tirzepatide (EloraTZP) led to weight loss of up to 23.3% in people living with obesity and type 2 diabetes


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Weight Loss

Weight Loss

Photo of Diabetes

Diabetes

Photo of Obesity

Obesity

Related news:

News photo

Adverse social determinants linked to higher dementia risk in people with type 2 diabetes

News photo

Two active magma reservoirs may lie beneath Masaya volcano, near 2 million people

News photo

No Longer Just North And South: A New Material Joins The Third Type of Magnetism

« CRISPR nanodroplet technology offers a new strategy for rapid, multiplexed, species-level identification of mycobacteria
FDA Approves First Drug To Treat Alexander Disease After 30 Years of Research »